Outcome measures in psoriatic arthritis clinical trials.

Soumya M. Reddy, Clifton Bingham

Research output: Contribution to journalArticle

Abstract

Outcome measures in psoriatic arthritis (PsA) have been primarily borrowed from the assessment of rheumatoid arthritis and ankylosing spondylitis, although several specific measures for PsA have been established. The advent of new therapeutic agents for the treatment of PsA has made the need for specific outcome measures for PsA more critical to evaluate the heterogeneous manifestations of this disease and features that are unique to its assessment. Several outcome measures have been validated for use in PsA clinical trials while others are being evaluated by groups such as The Group for Assessment of Psoriasis and Psoriatic Arthritis for future use in clinical trials.

Original languageEnglish (US)
Pages (from-to)299-305
Number of pages7
JournalCurrent Rheumatology Reports
Volume7
Issue number4
StatePublished - Aug 2005
Externally publishedYes

Fingerprint

Psoriatic Arthritis
Outcome Assessment (Health Care)
Clinical Trials
Ankylosing Spondylitis
Psoriasis
Rheumatoid Arthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Outcome measures in psoriatic arthritis clinical trials. / Reddy, Soumya M.; Bingham, Clifton.

In: Current Rheumatology Reports, Vol. 7, No. 4, 08.2005, p. 299-305.

Research output: Contribution to journalArticle

@article{1603cb307f9a4a03bae864e62d25ba33,
title = "Outcome measures in psoriatic arthritis clinical trials.",
abstract = "Outcome measures in psoriatic arthritis (PsA) have been primarily borrowed from the assessment of rheumatoid arthritis and ankylosing spondylitis, although several specific measures for PsA have been established. The advent of new therapeutic agents for the treatment of PsA has made the need for specific outcome measures for PsA more critical to evaluate the heterogeneous manifestations of this disease and features that are unique to its assessment. Several outcome measures have been validated for use in PsA clinical trials while others are being evaluated by groups such as The Group for Assessment of Psoriasis and Psoriatic Arthritis for future use in clinical trials.",
author = "Reddy, {Soumya M.} and Clifton Bingham",
year = "2005",
month = "8",
language = "English (US)",
volume = "7",
pages = "299--305",
journal = "Current Rheumatology Reports",
issn = "1523-3774",
publisher = "Current Science, Inc.",
number = "4",

}

TY - JOUR

T1 - Outcome measures in psoriatic arthritis clinical trials.

AU - Reddy, Soumya M.

AU - Bingham, Clifton

PY - 2005/8

Y1 - 2005/8

N2 - Outcome measures in psoriatic arthritis (PsA) have been primarily borrowed from the assessment of rheumatoid arthritis and ankylosing spondylitis, although several specific measures for PsA have been established. The advent of new therapeutic agents for the treatment of PsA has made the need for specific outcome measures for PsA more critical to evaluate the heterogeneous manifestations of this disease and features that are unique to its assessment. Several outcome measures have been validated for use in PsA clinical trials while others are being evaluated by groups such as The Group for Assessment of Psoriasis and Psoriatic Arthritis for future use in clinical trials.

AB - Outcome measures in psoriatic arthritis (PsA) have been primarily borrowed from the assessment of rheumatoid arthritis and ankylosing spondylitis, although several specific measures for PsA have been established. The advent of new therapeutic agents for the treatment of PsA has made the need for specific outcome measures for PsA more critical to evaluate the heterogeneous manifestations of this disease and features that are unique to its assessment. Several outcome measures have been validated for use in PsA clinical trials while others are being evaluated by groups such as The Group for Assessment of Psoriasis and Psoriatic Arthritis for future use in clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=27244436971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27244436971&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 299

EP - 305

JO - Current Rheumatology Reports

JF - Current Rheumatology Reports

SN - 1523-3774

IS - 4

ER -